ARCHIVES

Adjuvant XELOX More Effective Than 5-FU/LV For Stage III Colon Cancer

This article is from The Cancer Letter archive.

Vol. 33 No. 1 | January 29, 2010

Download PDF Visit The Full Archive

Related Articles

Regulatory Agencies: Groups Petition FDA To Ease Silicone Gel Implant Restrictions

September 27, 1996

Bioassay Program To NIEHS” NCI Denies Rumor

March 31, 1978

FDA Approves Medication For Smoking Cessation

May 26, 2006

DRCCA Concept Approvals; RFP For Evolution Of Three Programs; RFA For Cancer Care Of Elderly, New Physician Investigator Awards

October 29, 1982

Cancer Policy: Coffey Letter Lists Research Initiatives That Justify Increase

December 19, 1997

TJU Wins NCI Renewal Of Kimmel Center Core Grant; 11 NY Centers Testing Spiral CT.

July 13, 2001